As a leading healthcare company, Novartis provides Canadians with medicines to improve their health and quality of life, focusing on areas of significant unmet medical need.

At Novartis Canada, we are committed to working with all stakeholders within the health care ecosystem to ensure that every Canadian has equitable access to the innovative medicines they need. We are determined to be a valued partner and advocate, with a deep understanding of patient needs along the entire care journey – from drug development, to diagnosis, to access and beyond. Part of the way we are doing this is by leveraging data, technology, and partnerships.

We focus on five core therapeutic areas: Hematology, Solid Tumors, Cardiovascular, Neuroscience, and Immunology. We also develop and deliver treatments through other promoted and established brands, which today are helping millions of patients. Over the last five years, our average annual research and development investment in Canada was over $30 million, and we conduct clinical trial research in every region throughout Canada.

Novartis Canada employs approximately 900 associates from coast to coast.